Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and Kidney Failure

olmesartan has been researched along with Kidney Failure in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halleck, F; Holleck-Weithmann, S; Kossmehl, P; Kreutz, R; Rothermund, L; Schröder, K1
Akishita, M; Iijima, K; Ito, Y; Ouchi, Y; Son, BK1
Imanishi, M; Kitabayashi, C; Kobori, H; Kohno, M; Konishi, Y; Masaki, T; Mori, H; Morikawa, T; Nishiyama, A; Rafiq, K1
Friedrich, D; Gortner, L; Herkenrath, P; Hoppe, B; Hünseler, C; Kattner, E; Körber, F; Lindner, U; Müller, A; Oberthuer, A; Paneitz, A; Roth, B; Schaible, T; Schmitt, K; Welzing, L1
Kim, HJ; Rodríguez-Iturbe, B; Sato, T; Vaziri, ND1

Other Studies

5 other study(ies) available for olmesartan and Kidney Failure

ArticleYear
Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2015, Volume: 37, Issue:1

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Rats, Wistar; Receptors, Angiotensin; Renal Insufficiency; Tetrazoles

2015
Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification.
    Journal of atherosclerosis and thrombosis, 2014, Volume: 21, Issue:9

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Blood Pressure; Calcinosis; Drug Synergism; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Male; Pravastatin; Rats; Rats, Wistar; Renal Insufficiency; Tetrazoles

2014
Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Angiotensin Receptor Antagonists; Animals; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Combined Modality Therapy; Cytokines; Diet, Sodium-Restricted; Dihydropyridines; Drug Evaluation, Preclinical; Gene Expression; Gene Expression Regulation; Hypertension; Imidazoles; Kidney Glomerulus; Male; NADPH Oxidases; Rats, Inbred Dahl; Receptors, Mineralocorticoid; Renal Insufficiency; Tetrazoles

2014
Angiotensin II receptor blocker induced fetopathy: 7 cases.
    Klinische Padiatrie, 2011, Volume: 223, Issue:1

    Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Apgar Score; Benzimidazoles; Biphenyl Compounds; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; Hypertension, Pulmonary; Imidazoles; Infant, Newborn; Kidney; Lung; Male; Oligohydramnios; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Renal Insufficiency; Skull; Tetrazoles; Ultrasonography, Prenatal; Valine; Valsartan

2011
Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Progression; Glomerulosclerosis, Focal Segmental; Hypertension; Imidazoles; Kidney; Kidney Diseases; Male; NF-E2 Transcription Factor; NF-kappa B; Oxidative Stress; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Tetrazoles; Thiobarbituric Acid Reactive Substances

2011